- application for registration
- Coalition for Medical Marijuana Research and Education
- Department of Health
- DFMMJ Investments
- Division of Administrative Hearings
- H. Lee Moffitt Cancer Center and Research Institute
- John Lockwood
- Liberty Health Sciences
- marijuana regulators
- Medical marijuana
- medicinal cannabis
- Office of Medical Marijuana Use
- rule challenges
- Supplemental Licensing Fee
- variance procedure
State regulators have given up for now on a contentious rule requiring a hefty fee from medical marijuana suppliers.
But the office on Monday, without explanation, announced it was withdrawing the proposed fee from further consideration.
It already had drawn a legal challenge from Liberty Health Sciences, a state-licensed “medical marijuana treatment center” (MMTC).
Its lawyer had argued the state set the fee too high.
“I understand the department will conduct future rulemaking proceedings on this subject and my client looks forward to discussing their concerns,” said John Lockwood, the company’s Tallahassee-based attorney.
In an email, Health Department spokesman Devin Galetta added that the department “is working to ensure that input presented by stakeholders during the rulemaking process is addressed.”
The fee in question was to be an “annual payment by a registered (provider) to cover the (state’s) costs of administering” the law governing medicinal cannabis.
Lockwood said in a filing with the agency that the calculation requires the state’s 13 currently licensed MMTCs “to bear the burden of the supplemental licensure fee when the fee should be borne by at least 17 MMTCs” — which would bring it down to around $133,000, a 24 percent decrease.
The money from the fee would help fund the Coalition for Medical Marijuana Research and Education within the H. Lee Moffitt Cancer Center and Research Institute in Tampa.
Lawmakers gave it a mission “to conduct rigorous scientific research, provide education, disseminate research, and guide policy for the adoption of a statewide policy on ordering and dosing practices for the medical use of marijuana.”
Liberty Health Sciences’ other challenge on a “variance procedure” for MMTCs is still pending; a hearing is set for next Friday. Both challenges were filed in the state’s Division of Administrative Hearings.
The idea behind the latter rule, for one example, was to allow providers who had originally applied to use a certain marijuana processing procedure to later ask to use a newer, better technology.
But Liberty’s challenge there suggests it could also cause administrative nightmares by “requiring an MMTC to request a variance before hiring or firing any employee or manager.”
Liberty Health Sciences is a subsidiary of Canadian-based DFMMJ Investments, which itself was formerly partly owned by Aphria, a Canadian producer of medical cannabis products. Liberty has dispensaries in Summerfield, St. Petersburg, Tampa and Port St. Lucie.